Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic metastasis of pancreatobiliary origin

BACKGROUND: Gemcitabine, a chemotherapy for hepatic metastasis with pancreatic cancer (PC) or intrahepatic cholangiocarcinoma (ICC) origin, may radiosensitize the targeted tumor cells for yttrium-90 radioembolization (90Y-RE). This clinical trial was designed to investigate the effects of a combinat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastrointest Oncol
Hlavní autoři: Nezami, Nariman, Camacho, Juan C., Kokabi, Nima, El-Rayes, Bassel F., Kim, Hyun S.
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6776801/
https://ncbi.nlm.nih.gov/pubmed/31602333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.05.10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky